NDC 41163-150

equaline lansoprazole

Lansoprazole

equaline lansoprazole is a Oral Capsule, Delayed Release in the Human Otc Drug category. It is labeled and distributed by Supervalu Inc. The primary component is Lansoprazole.

Product ID41163-150_5c97e90e-71f6-4970-834b-f66e00a8605b
NDC41163-150
Product TypeHuman Otc Drug
Proprietary Nameequaline lansoprazole
Generic NameLansoprazole
Dosage FormCapsule, Delayed Release
Route of AdministrationORAL
Marketing Start Date2021-09-02
Marketing CategoryANDA /
Application NumberANDA202319
Labeler NameSupervalu Inc
Substance NameLANSOPRAZOLE
Active Ingredient Strength15 mg/1
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 41163-150-01

1 BOTTLE in 1 CARTON (41163-150-01) > 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE
Marketing Start Date2021-09-02
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "equaline lansoprazole" or generic name "Lansoprazole"

NDCBrand NameGeneric Name
41163-117equaline lansoprazoleequaline lansoprazole
0113-7003Basic Care LansoprazoleLansoprazole
0113-7116basic care lansoprazoleLansoprazole
0113-0116Good Sense LansoprazoleLansoprazole
0113-0117Good Sense lansoprazoleLansoprazole
0113-1114Good Sense LansoprazoleLansoprazole
0093-3008LansoprazoleLansoprazole
0093-3009LansoprazoleLansoprazole
0093-7350LansoprazoleLansoprazole
0093-7351LansoprazoleLansoprazole
0067-6286PrevacidLansoprazole
0113-6002Prevacid 24 HRlansoprazole

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.